Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · Real-Time Price · USD
5.23
+0.14 (2.75%)
At close: May 12, 2025, 4:00 PM
5.07
-0.16 (-3.06%)
After-hours: May 12, 2025, 5:28 PM EDT
Titan Pharmaceuticals Employees
Titan Pharmaceuticals had 4 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,176,500
Market Cap
4.78M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TTNP News
- 4 weeks ago - Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock - GlobeNewsWire
- 5 months ago - Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq - GlobeNewsWire
- 9 months ago - TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP - Business Wire
- 9 months ago - Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd. - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces Reverse Stock Split and Ratio - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock - GlobeNewsWire